These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32411264)

  • 21. Fact or fiction: does the non-HIV/AIDS immunosuppressed patient need Pneumocystis jiroveci pneumonia prophylaxis? An updated literature review.
    Grewal P; Brassard A
    J Cutan Med Surg; 2009; 13(6):308-12. PubMed ID: 19919808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.
    Diri R; Anwer F; Yeager A; Krishnadasan R; McBride A
    Transpl Infect Dis; 2016 Feb; 18(1):63-9. PubMed ID: 26606757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study.
    Yu Q; Jia P; Su L; Zhao H; Que C
    BMC Infect Dis; 2017 Jun; 17(1):392. PubMed ID: 28583135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytomegalovirus infection and graft rejection as risk factors for pneumocystis pneumonia in solid organ transplant recipients: A systematic review and meta-analysis.
    Hosseini-Moghaddam SM; Krishnan RJ; Guo H; Kumar D
    Clin Transplant; 2018 Aug; 32(8):e13339. PubMed ID: 29956379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: A systematic review.
    Messiaen PE; Cuyx S; Dejagere T; van der Hilst JC
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28035717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cytological diagnosis of
    Kapatia G; Saikia A; Mohapatra DS; Gupta P; Rohilla M; Gupta N; Srinivasan R; Rajwanshi A; Dey P
    Cytojournal; 2023; 20():2. PubMed ID: 36751555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pneumocystis jirovecii pneumonia in children. A retrospective study in a single center over three decades.
    García-Moreno J; Melendo-Pérez S; Martín-Gómez MT; Frick MA; Balcells-Ramírez J; Pujol-Jover M; Martín-Nalda A; Mendoza-Palomar N; Soler-Palacín P
    Enferm Infecc Microbiol Clin (Engl Ed); 2020 Mar; 38(3):111-118. PubMed ID: 31272810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pneumocystis jiroveci pneumonia in inflammatory bowel disease: when should prophylaxis be considered?
    Okafor PN; Nunes DP; Farraye FA
    Inflamm Bowel Dis; 2013 Jul; 19(8):1764-71. PubMed ID: 23615530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.
    Evernden C; Dowhan M; Dabas R; Chaudhry A; Kalra A; Dharmani-Khan P; Gregson D; Johnson A; Jupp J; Jimenez-Zepeda V; Jamani K; Duggan P; Tay J; Khan F; Daly A; Storek J
    Cytotherapy; 2020 Jan; 22(1):27-34. PubMed ID: 31889628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of an intravenous trimethoprim/sulfamethoxazole shortage on treatment outcomes among HIV-infected patients with Pneumocystis jirovecii pneumonia.
    Dilworth TJ; Ibrahim OM; Mercier RC
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1246-54. PubMed ID: 25443518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower Mortality Associated With Adjuvant Corticosteroid Therapy in Non-HIV-Infected Patients With
    Mundo W; Morales-Shnaider L; Tewahade S; Wagner E; Archuleta S; Bandali M; Chadalawada S; Johnson SC; Franco-Paredes C; Shapiro L; Henao-Martínez AF
    Open Forum Infect Dis; 2020 Sep; 7(9):ofaa354. PubMed ID: 33005696
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Gentile I; Viceconte G; Lanzardo A; Zotta I; Zappulo E; Pinchera B; Scotto R; Schiano Moriello N; Foggia M; Giaccone A; Messina G; Salvatore P; Buonomo AR; Federico Ii Covid-Team
    Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Previous corticosteroid exposure associates with an increased
    Vargas Barahona L; Molina KC; Pedraza-Arévalo LC; Sillau S; Tagawa A; Scherger S; Chastain DB; Shapiro L; Tuells J; Franco-Paredes C; Hawkins KL; Maloney JP; Thompson GR; Henao-Martínez AF
    Ther Adv Infect Dis; 2023; 10():20499361231159481. PubMed ID: 36938147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Narrative review of the relationship between COVID-19 and PJP: does it represent coinfection or colonization?
    Chong WH; Saha BK; Chopra A
    Infection; 2021 Dec; 49(6):1079-1090. PubMed ID: 34059997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant Patients.
    Brakemeier S; Dürr M; Bachmann F; Schmidt D; Gaedeke J; Budde K
    Transplant Proc; 2016 Nov; 48(9):2924-2930. PubMed ID: 27932109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis.
    Williams KM; Ahn KW; Chen M; Aljurf MD; Agwu AL; Chen AR; Walsh TJ; Szabolcs P; Boeckh MJ; Auletta JJ; Lindemans CA; Zanis-Neto J; Malvezzi M; Lister J; de Toledo Codina JS; Sackey K; Chakrabarty JL; Ljungman P; Wingard JR; Seftel MD; Seo S; Hale GA; Wirk B; Smith MS; Savani BN; Lazarus HM; Marks DI; Ustun C; Abdel-Azim H; Dvorak CC; Szer J; Storek J; Yong A; Riches MR
    Bone Marrow Transplant; 2016 Apr; 51(4):573-80. PubMed ID: 26726945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risk factor analysis and treatment experience in pneumocystis jirovecii pneumonia after kidney transplantation.
    Yang P; Zhu X; Liang W; Cai R
    Mycoses; 2021 May; 64(5):495-502. PubMed ID: 33368732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pneumocystis jirovecii and quantitative PCR: Pneumonia or colonization?].
    Gazaignes S; Bergeron A; Menotti J; Desseaux K; Molina JM; De Castro N
    Rev Mal Respir; 2020 Apr; 37(4):299-307. PubMed ID: 32273116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience.
    Mecoli CA; Saylor D; Gelber AC; Christopher-Stine L
    Clin Exp Rheumatol; 2017; 35(4):671-673. PubMed ID: 28134084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of Pneumocystis jirovecii and Adverse Events Associated With Pneumocystis Prophylaxis in Children Receiving Glucocorticoids.
    Basiaga ML; Ross ME; Gerber JS; Ogdie A
    J Pediatric Infect Dis Soc; 2018 Dec; 7(4):283-289. PubMed ID: 28992298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.